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Background: Worldwide, the organisation of diabetes care is changing. As a result general practices and diabetes
teams in hospitals are becoming part of new organisations in which multidisciplinary care programs are
implemented. In the Netherlands, 97 diabetes care groups and 104 outpatient clinics are working with a diabetes
care program. Both types of organisations aim to improve the quality of diabetes care. Therefore, it is essential to
understand the comprehensive elements needed for optimal quality management at organisational level. This
study aims to assess the current level of diabetes quality management in both care groups and outpatient clinics
and its improvement after providing feedback on their quality management system and tailored support.
Methods/design: This study is a before-after study with a one-year follow-up comparing the levels of quality
management before and after an intervention to improve diabetes quality management. To assess the status of
quality management, online questionnaires were developed based on current literature. They consist of six
domains: organisation of care, multidisciplinary teamwork, patient centeredness, performance management, quality
improvement policy and management strategies. Based on the questionnaires, respondents will receive feedback
on their score in a radar diagram and an elucidating table. They will also be granted access to an online toolbox
with instruments that proved to be effective in quality of care improvement and with practical examples. If
requested, personal support in implementing these tools will be available. After one year quality management will
be measured again using the same questionnaire.
Discussion: This study will reveal a nationwide picture of quality management in diabetes care groups and
outpatient clinics in the Netherlands and evaluate the effect of offering tailored support. The operationalisation of
quality management on organisational level may be of interest for other countries as well.
Keywords: Type 2 diabetes, Quality management, Quality improvement, Care groups, Outpatient clinics,
Questionnaire, Integrated care, Shared care, Disease managementBackground
Worldwide, the number of type 2 diabetes mellitus patients
(T2DM) is rising rapidly [1]. This poses great challenges to
cost, efficacy and quality of diabetes care. Diabetes care
usually involves many health care providers. Consequently,
optimal collaboration and coordination among profes-
sionals has become essential for delivering high quality of* Correspondence: m.j.e.campmans-kuijpers@umcutrecht.nl
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distribution, and reproduction in any mediumcare [2]; in addition, this care should be organised in a
patient centred way [3]. Organisations providing diabetes
care are obliged to control these complex processes by
quality management (QM). QM comprises procedures to
monitor, assess and improve the quality of care [4]. Besides
focussing on patient related and process outcomes, also
other aspects of QM on an organisational level are likely to
become crucial in order to maintain or enhance the
delivery of good quality diabetes care [5].
In the Netherlands, patients with type 2 diabetes are
in principle treated in primary care. Patients, who needMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Campmans-Kuijpers et al. BMC Health Services Research 2013, 13:129 Page 2 of 10
http://www.biomedcentral.com/1472-6963/13/129more complex care, are treated in secondary care [6]. In
primary care, most patients (80-85%) are treated within
so called diabetes care groups (DCGs) [7]. These DCGs,
comparable with Accountable Care Organizations (ACOs)
[8,9] in the United States and Clinical Commission
Groups (CCGs) [10] in the United Kingdom, emerged
after the introduction of bundled payment in 2007 [11].
DCGs are the main contractor of a diabetes care program,
and are responsible for the organisation, coordination and
delivery of diabetes care. They comprise between three
and 250 general practitioners (GPs) [12]. The diabetes care
program is based on the Dutch Diabetes Federation
Health Care Standard (DFHCS) for T2DM [13]. Patients
who need more complex diabetes care are treated in 104
diabetes outpatient clinics (DOCs). Besides the DFHCS
standard, the latter have special guidelines for treatment
of a diabetic foot, retinopathy, nephropathy [6,14].
The organisation of DCGs [15] and DOCs [16] varies
widely. In DOCs the organisation is managed by the
hospital department itself, although the endocrinologist
is mainly responsible for the quality of diabetes care. In
the DCGs, managers, managing directors or GPs are in
charge of a whole care group; their type of organisation
varies with regard to the type of legal entity, the owner-
ship of the care group and the number of employees
[15]. Also the number of patients treated in both DCGs
(400–22,500) [12] and DOCs (250–4,500) varies widely.
Both DCGs and DOCs strive to deliver good quality of
care for type 2 diabetes patients. Very recently, Tricco
et al. (2012) stated that targeting the system in chronic
care management is important in improving diabetes
care [17]. So far, little attention has been paid to QM on
an organisational level. Therefore, this study focuses on
improving quality of diabetes care at an organisational
level by improving QM.
First, we want to study the current level of QM in
all DCGs and DOCs in the Netherlands. Based on the
baseline measurement participating organisations will
be given feedback; this will show them their strengths
and weaknesses in QM. Next, they will be provided
access to a toolbox for QM and offered the possibility
of tailored support. After one year we will examine
their level of QM again.
In this paper we describe the study design and the




This study is a before-after study with a one-year follow-up
comparing the levels of QM before and after an inter-
vention to improve QM within DCGs and DOCs. The
study was funded by the Dutch Diabetes Federation
(grant no NAD 3.05) and no ethical approval was neededbecause the study does not meet the WMO (Wet Medisch
wetenschappelijk Onderzoek) criteria for medical human
scientific research [18].
Defining quality of care and quality management
There are many definitions of quality of care depending on
the perspective used. Patients mainly focus on effectiveness
and access of care, and they expect consistent information.
Care providers and insurers want to deliver effective care
according to the latest standards appropriate for their
patients. For care managers and insurers efficiency and
safety of care are main issues. Hence, good quality of care
can be defined as ‘care of a high standard that is effective,
efficient, safe and patient oriented’ [19].
Quality of care is not merely a random outcome, but
at least partially the outcome of a controlled process:
quality management. Thus, QM can be defined as “all
procedures explicitly designed to monitor, assess, and
improve the quality of care” [4].
Operationalising and measuring QM
To measure the level of QM, a suitable questionnaire
was needed. Therefore, we first formulated criteria for
measuring diabetes QM. A suitable questionnaire should
target the organisational level of health care organisations
and focus on diabetes care.
We performed an extensive literature search for suitable
questionnaires in the MEDLINEW, EMBASEW, CINAHLW,
and Cochrane databases and in the Cochrane registry for
terms relevant to diabetes type 2 and outpatient clinics,
ambulatory care, managed care, shared care, integrated
care, coordinated care, Accountable Care Organizations,
Health Maintenance Organization, disease management,
and quality improvement, total quality management, con-
tinuous quality improvement or Plan-Do-Check-Act cycle.
For the exact search terms see Additional file 1.
No questionnaires measuring QM at an organisational
level were found in medical literature (Figure 1). Conse-
quently, we had to develop a questionnaire ourselves; there-
fore we first needed to itemize the domains we considered
crucial in QM. Hence, we studied health care models,
including those based on industrial models, to see how
QM was operationalised. We found seven models
containing different domains of QM: the Chronic Care
Model (CCM) [20]; the ‘Harmonisatie Kwaliteitsbeoordeling
in de Zorgsector’ (HKZ: Harmonisation Quality Assessment
in Health Care) model, based on ISO 9001 [21]; The
Malcolm Baldrige USA National Quality Award (MBQA)
[22]; The European Foundation for Quality Management
(EFQM) [23]; the ‘Instituut Nederlandse Kwaliteit’ (INK:
Institute for Dutch Quality) model from the Dutch
Governmental foundation, based on the above mentioned
EFQM [24,25]; and a measuring instrument developed
by C. Wagner, which was later adapted in the Quality
Figure 1 Flowchart of search for questionnaires suitable for
measuring diabetes QM on organisational level.
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naire [26,27]; and the Developmental Model for Integrated
Care (DMIC) [28].
Comparing these seven models (Table 1), nine common
domains of QM emerged. Here we describe these common
domains, albeit sometimes with different labels.
1. Organisation of care: The CCM mentions ‘delivery
system design’. According to the CCM ‘Clinical
information systems’ are necessary to be able to
build an effective ‘delivery system design’ and are
therefore considered part of the organisation of care.
Organisation of care is further reflected in DMIC by
‘delivery system’, in MBQA by ‘management of
process quality’, in EFQM by ‘processes’ and in INK
by ‘management of processes’, QSMH mentions
‘process control based on standards’ and ‘quality
assurance documents’. Hence, we will regard
organisation of care as a separate domain.
2. Multidisciplinary teamwork: DMIC mentions
‘inter-professional teamwork’ and HKZ ‘care chain
quality’. In the CCM multidisciplinary teamwork is
not described as a domain, however, the CCM
explicitly aims to create a productive interaction
between an informed, activated patient and a
prepared, proactive practice team. In MBQA,
EFQM, INK and QSMH models multidisciplinary
teamwork is not a separate domain. However,
‘partnership & resources’ of EFQM can be
interpreted as multidisciplinary teamwork. As
multidisciplinary teamwork is essential in organising
diabetes care, we will consider it a separate domain.
3. Patient centeredness is a special domain in the
DMIC; HKZ lists ‘focus on client perspective’. In CCMpatient centeredness is reflected in ‘self-management
support’, QSMH measures ‘involvement of patients’,
and MBQA lists ‘customer focus and satisfaction’.
Patients are mentioned as ‘clients and partners’ by INK
and as ‘customer results’ by EFQM. As diabetes care
should be organised patient centred [3], patient
centeredness will be a special domain.
4. Performance management: is mentioned in DMIC.
In MBQA performance results is reflected in
‘information and analysis’. EFQM has four boxes for
results; within these boxes performance
management is reflected by ‘key performance
results’. INK lists four result dimensions; but they do
not explicitly mention performance management. In
HKZ results are part of the domain ‘improvement’.
CCM focuses more on the care process, less on
results, although ‘decision support’ and ‘clinical
information systems’ both support performance
management. QSMH includes ‘process improvement
based on QI procedures’. Performance management
will be a domain in our questionnaire. At
organisational level we will be mainly interested in
which results are measured in what way and how
these results are handled.
5. Quality improvement (QI) policy: is mentioned by
MBQA as ‘quality and operational results’ and by
HKZ as ‘improvement’ and ‘client safety’. In DMIC
‘result-focused learning’ and ‘quality care’ together
cover QI. Both EFQM and INK define QI as the
main purpose of the model. EFQM and INK both do
mention ‘strategy and policy’. QSMH mentions
‘process improvement based on QI procedures’.
CCM mentions ‘decision support’ to improve the
knowledge and skills of providers; this can be seen
as part of QI policy. On the other hand, the aim of
the whole CCM is to guide QI in chronic care. Since
QI is likely to be one of the major aims of each QM
organisation, it will be a separate domain in our tool.
6. Management strategies and leadership are
reflected in the followings domains of the models:
‘health care organization’ (CCM), ‘professional
behaviour’ and ‘ISO-compatibility’ (HKZ),
‘leadership’ (MBQA, EFQM, INK). MBQA also
mentions ‘strategic quality planning; INK mentions
‘management and financiers’ and ‘management of
resources’. Leadership is important in the QSMH
model too, but it states it is difficult being measured
without bias [26]; therefore they concentrate on
‘quality assurance documents’. DMIC divides
leadership into three clusters: ‘roles and tasks’,
‘commitment’ and ‘transparent entrepreneurship’.
Since management is responsible for the mission
and coordination of care, it will be a separate
domain in our questionnaire, taking bias on
Table 1 Different domains across different quality management systems
CCM HKZ MBQA EFQM INK QSMH DMIC
A framework to guide QI in
chronic care. CCM aims to
create a productive interaction
between an informed, activated
patient and a prepared,
proactive practice team.





in healthcare QI by creating
awareness of the importance
of QI, recognition of
accomplishments and
information transfer
A European model which
supports organisations to
self-assess and reflect its
level of organization in
order to improve its
organization.
A model based on EFQM to
support profit and non-profit
organizations to get to
excellent achievements
A measuring instrument





HKZ is based on ISO 9001
• community resources • improvement • leadership 5 boxes for enablers: 5 organisational dimensions: 5 focal areas for QI
activities:
9 clusters:
• health care organisation • focus on client
perspective
• Information and analysis • leadership • leadership • quality assurance
documents
• patient-centeredness
• self-management support • client safety • strategic quality planning • people • strategy and policy • involvement of patients • delivery system
• decision support • professional behaviour • human resource
development and
management




• delivery system design • care chain quality • management of process
quality
• partnership& resources • management of resources • human resources
management
• quality care
• clinical information system • ISO-compatibility • quality and operational
results
• processes • management of processes • process improvement
based on QI procedures
• result-focused learning
• customer focus and
satisfaction
4 boxes for results: 4 result dimensions: • interprofessional
teamwork
• people results • clients and partners • roles and tasks
• customer results • personnel • commitment
• society results • community • transparent
entrepreneurship• key performance results • management and financiers
CCM: Chronic Care Model; HKZ: Harmonisatie Kwaliteitsbeoordeling in de Zorgsector (Harmonisation Quality Assessment in Health Care); MBQA: The Malcolm Baldrige USA National Quality Award; EFQM: The European
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reduce this bias, the term leadership will be left out in
the name of this domain.
7. Personnel are considered a separate domain in the
MBQA reflected by ‘human resource development
and management’; in EFQM by ‘people’ and ‘people
results’; in INK by ‘management of employees’ and
‘personnel’. QSMH is focussed on hospitals and
mentions ‘human resources management’. CCM
does not have a domain for personnel. HKZ does
not mention personnel. We will not regard
personnel as a separate domain because care groups
are very differently organised; in some of them the
central organisation only consists of one director. In
hospitals the organisation consists of more
personnel. However, the training of diabetes care
providers remains an important issue; it will be
covered in the domain ‘quality improvement policy’.
8. Safety is only mentioned by HKZ. Though it is an
important part of quality and QM as well, we think
it could be covered by ‘quality improvement policy’.
9. Community is mentioned as ‘community resources’ in
CCM and ‘community’ in INK and ‘society results in
‘EFQM’. Because our focus is on the organisation itself,
we will not regard community as a special domain.
After thorough discussions between the authors about
the different domains of QM, consensus was reached to
distinguish six domains within diabetes care QM, namely:
organisation of care, multidisciplinary teamwork, patient
centeredness, performance management, quality improve-
ment policy and management strategies. These domains
were then operationalised into sub-domains, to be more
specific about the content/definition of the domains. Based
on the above mentioned models we defined a total of 28
sub-domains, which are shown in Table 2.
Questionnaire
Based on the domains and sub-domains, two separate,
yet comparable questionnaires for DCGs and for DOCs
were developed to be able to adjust to different organisa-
tional backgrounds in DCGs and DOCs. In a pilot study,
both draft questionnaires were tested by four and five
experts from primary and secondary care respectively.
For each sub-domain one to six questions were included
in the final questionnaires; the total number of questions
amounts to 51 for DCGs and 48 for DOCs. In the DCG
questionnaire, the diabetic foot team was left out; and
the DOC questionnaire contained a looping to prevent
posing irrelevant questions.
Weighing of sub-domains
Theoretically, all questions can be weighted equally with
one point (thus giving each sub-domain equal importancewithin a domain) or the questions can be weighted by an
expert panel [29]. We asked two expert panels to weigh
the sub-domains: the DCG expert panel consisted of seven
managers, one staff member, one quality manager and one
diabetes nurse; a DOC expert panel consisted of two
managers, three endocrinologists and four diabetes nurses.
There were significant differences (one-sample t-tests) be-
tween equal weighting of each sub-domain and the weight
given by the expert panels. Therefore, each question will be
given one point; all questions together within a sub-domain
contribute X% to the maximum score of a domain, where
X is the mean weight given by the corresponding expert
panel (Table 2). For each organisation the score in the
domains and sub-domains will be computed. The total
score on QM is the mean score of all domains.
Agreement and validity of questionnaire
To test the validity of the questionnaire the percentage
of agreement will be checked by inviting two persons of
the same organisations to fill out the questionnaire.
Improving QM
Study population and recruitment
All DCGs (n = 97) and DOCs (N = 104) will be invited to
fill out the online questionnaires. Two persons per organi-
sations will be given the opportunity to do so. Personal
email-addresses will be collected for this invitation, to be
able to send participants the results personally. This policy
will offer participants the opportunity to determine with
whom they want to share their results. After two and four
weeks reminders will be sent. After six weeks people who
partly completed the questionnaire will be emailed and
phoned to complete their questionnaire.
Intervention
The intervention consists of 1. giving organisations
feedback on their current level of diabetes QM based
on the scores of the questionnaire; 2. providing access
to a toolbox for QM; and 3. offering the possibility of
tailored support.
Feedback Within one month after responding on the
online questionnaire, the responders will be given feedback
on the level of the diabetes QM in their organisation. To be
able to quickly discern their strengths and weaknesses in
QM, their results will be presented in a radar diagram
consisting of the six QM domains (Figure 2) and in a table
elucidating the scores of the domains and sub-domains;
both results will be compared to the results of the group of
DCGs / DOCs as a whole (Table 3).
Access to online toolbox Together with receiving
feedback, all participants will receive an e-mail letter
elucidating the feedback and granting them access to
Table 2 Results of the weighing of the importance of sub-domains within domains by two expert panels














Organisation of care 13: 100.0 9: 100.0
Care program 4 34.6 33.3(25–50) ns 4 32.0 33.3(20–50) ns
Continuity and Coordination 6 31.5 30(25–50) ns 2 31.5 33.3(20–40) ns
Communication and Information 3 34.0 33.2(20–50) ns 3 36.5 33.3(25–60) ns
Multidisciplinary teamwork: 15: 100.0 16: 100.0
Work agreement 4 24.0 25(11–33) ns 3 23.0 20(10–50) ns
Tasks and responsibilities 3 25.4 25(17–35) ns 3 23.5 20(10–50) ns
Teamwork/ consultation/
shared education/ guidelines
5 26.0 25(16–34) ns 6 16.3 16.7(10–25) ns
Transfer and referral 3 24.6 25(13–42) ns 3 17.8 20(10–25) ns
Diabetic foot team - - - - 1 19.4 20(5–30) ns
Patient centeredness: 7: 100.0 7: 100.0
Self-management 1 20.2 20(5–35) ns 1 31.1 30(5–60) 0.04
Individual care plan 1 18.7 18.3(10–30) ns 1 12.3 15(5–20) 0.03
Policy on patient education 1 12.2 12.5(5–20) 0.02 1 17.3 16(5–30) ns
Inspection of medical file 2 13.7 15(5–20) ns 2 11.8 10(5–16) 0.00
Patient interests 1 16.2 15(10–25) ns 1 12.9 10(5–20) ns
Patient involvement 1 19.2 15.8(10–40) ns 1 14.6 10(10–40) ns
Performance management: 8: 100.0 8: 100.0
Registering results 1 28.0 25(10–40) ns 1 30.6 30(10–55) 0.04
Control of results 1 18.5 20(5–30) ns 1 20.6 20(10–40) ns
Processing of results 2 16.5 17.5(5–40) ns 2 10.6 10(5–20) 0.00
Analysing results 2 16.0 17.5(5–30) ns 2 17.8 15(10–50) ns
Performance indicators 2 21.0 20(10–40) ns 2 20.6 20(10–30) ns
Quality improvement: 11: 100.0 11: 100.0
Elements of QI 1 12.5 10(0–30) ns 1 12.8 15(0–20) ns
Feedback/ benchmark 2 25.5 27.5(15–30) 0.00 2 17.2 20(0–30) ns
Visitation 2 19.5 20(0–40) ns 1 21.1 20(10–35) ns
Education 2 21.0 20(10–35) ns 2 15.0 20(0–20) ns
Patient safety 2 9.5 10(0–20) 0.01 3 18.3 15(10–35) ns
Defining sub-groups 2 12.0 12.5(0–25) ns 2 15.6 15(0–30) ns
Management strategies: 5: 100.0 6: 100.0
Structural policy 3 54.7 50(33–100) 0.02 3 47.9 40(33–100) ns
Quality system 1 16.3 20(0–33) 0.01 1 22.3 27.5(0–40) 0.03
Quality documents 1 29.0 33(0–40) ns 2 29.8 31.7(0–50) ns
*Significant difference versus equally weighting: ns = not significant.
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ments for QI and practical examples of good practices
in diabetes care per domain. Participating DCGs and
DOCs will also be given the opportunity to share tools
with other organisations. These tools should clearly
been described and tested and proven effective or they
have been developed in an evidence based manner or
they are proven effective in an interventional study.
The use of the toolbox will be monitored during the
one-year follow-up period, to quantify its use.Tailored support on request Within a three months
period after the feedback with the radar diagram, all
respondents will be telephonically asked about whether
they studied the feedback, looked into the toolbox or
discussed the results within their organisation and whether
they need support in improving their QM. If so, tailored
support can be provided in three different ways: firstly,
more information on the study or the results of the
questionnaire, secondly, advice by phone or thirdly a visit
by two experienced quality consultants. In these latter
Figure 2 An example of feedback to a care group.
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pating organisation analyse which gaps in QM could
be tackled first. The consultants can give suggestions,
offer supportive tools or show the participants how to
initiate a QI strategy; for this purpose they have dedicated
time up to a maximum of ten hours per organisation. The
kind of support that will be given and the time spent will
be monitored.Outcome measures
The scores in the six domains and 28 sub-domains
will be calculated using the mean weight given by the
corresponding expert panel. The overall score in QM
of an organisation is the mean score of the six domains.
The overall score of the whole group will reflect the level
of QM in DCGs and DOCs.
After one year, we will measure the level of QM again
and in the same way. The change in QM will be computed
as the difference in the overall score in QM at the start of
the study and after one year. Further, the one-year change
of the separate domains will be computed, to assess which
domain changed the most.
For measurements concerning the intervention, the
quality consultants will register the time spent on the
support of each organisation. After one year, the par-
ticipating organisations will be asked whether the first
feedback triggered them to adapt parts of their QM
policy and if yes; which parts. Further, they will be
asked whether they used the toolbox and how much time(hours, rough estimation) they spent extra on QM during
the intervention.
To assess the generalisability of the study results and
check whether selection bias occurred, organisations
who did not participate will be asked how many diabetes
patients are being treated by their organisation and how
they judge their own level of QM. For this judgement we
will use a multiple choice question with the following
options: 1. insufficiently developed; 2. under development;
3. well developed; and 4. excellently developed, including
a cyclic quality management policy.
Statistical analysis
The scores, mean scores and standard deviation (if no
normality: median and range) of domains, sub-
domains and the overall mean will be computed for
both DCGs and DOCs. Ranges of the overall score
will be determined to show the differences in the
level of QM within DOCs and DCGs.
After one year, dependent t-tests (if no normality:
Wilcoxon matched pairs signed rank sum T test) will show
whether changes occurred in the overall score and the
domain scores. Linear regression analysis will be used to
analyse the association between the hours spent on the
intervention and the one-year change in overall score.
Univariable regression will be used to assess the
relationship between the use of the toolbox, hours spent
by the quality advisors and hours the organisation
additionally spent on QI (determinants) and change in
overall QM (dependent variable). To test generalisability,
Table 3 An example of feedback to a care group
Domains Sub domains Your organisation [%] Mean score care groups [%]
1 Organisation of Care
Care program 90 81
Continuity and coordination 60 72
Communication en information 21 49
*Mean weighted score organisation of care: 58 67
2 Multidisciplinary teamwork
Work agreement 61 60
Tasks and responsibilities 78 92
Teamwork/consultation /shared education /guidelines 45 74
Transfer and referral 75 68
*Mean weighted score multidisciplinary teamwork: 64 74
3 Patient centeredness
Self-management 25 94
Individual care plan 33 30
Policy on patient education 50 58
Inspection of medical file 17 39
Patient interests 71 60
Patient involvement 67 14
*Mean weighted score patient centeredness: 44 49
4 Performance management
Registering results 63 60
Control of results 40 27
Processing of results 100 67
Analysing results 68 56
Performance indicators 100 94
*Mean weighted score performance results: 73 61
5 Quality improvement policy
Elements of quality improvement 60 38
Feedback/ benchmark 100 73
Visitation 60 43
Education 100 67
Patient safety 0 22
Defining sub-groups 33 53
*Mean weighted score quality improvement policy: 69 54
6 Management Strategies
Structural policy 92 66
Quality system 67 56
Quality documents 40 72
*mean weighted score on management strategies: 73 66
mean total score quality management 64 62
*The weight of a sub-domain within a domain is determined by consulting experts.
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a difference in the number of patients treated by
responding and non-responding organisations. Besides,
the median score of the level of QM in the non-responder
group will be computed and compared with the level in
the responder group.To check validity of the questionnaire, actual agreement
between two respondents of the same organisation will be
computed. Since both questionnaires contain a wide variety
of questions with three to seven answering categories and
on top of that multiple answering was possible, there will
be no correction for expected agreement.
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assumptions for regression analysis will be checked. For
all tests P-values <0.05 will be considered significant.
Analysis will be performed using the SPSS 20.0 statistic
software package.
Discussion
This study will provide an overview of the current level of
quality management in diabetes care groups and diabetes
outpatient clinics across the Netherlands. It will give insight
into the possibility to change this level with a relatively
simple intervention. If participating organisations are able
to improve QM by our intervention, we expect that this
might lead to improved quality of care and subsequently
to improved patient outcomes. Tricco et al. already stated
that targeting the system of chronic disease management
should be regarded important in improving diabetes
management [17].
There were no questionnaires available to measure
QM in DCGs and DOCs. Therefore, we had to develop
these ourselves. This allowed us to operationalise QM
specially tailored to QM in DCGs and DOCs. This
operationalisation might also be relevant for ACOs and
CCGs and other DOCs because they will probably be
confronted with the same aspects of QM as well. Therefore,
our operationalisation of QM may be an asset for
measuring QM at institutional level. The online question-
naires contain multiple response questions which are easy
to access and simple to fill out.
Our questionnaire is not completely validated. However,
we expect there is sufficient internal validity because of the
search strategy and the expert consultation. Specifically,
face validity [29] is addressed as draft questionnaires were
piloted by experts and their comments were processed;
both final questionnaires were weighted by expert panels.
Further, the percentage of agreement will be checked by
inviting two persons of the same organisations to fill out
the questionnaire.
Another limitation we have to address is the bias that
might be introduced because of social desirable answering
[30]. To overcome this problem, we operationalised
management strategies and leadership as much as possible
by questioning ‘management strategies’. Social desirability
however seems unlikely, because individual feedback was
guaranteed in order to enable participants to learn from
the results and to stimulate them to improve the QM of
their organisation.
Regarding generalisability of the results, it might be
possible that especially those organisations will respond,
who already have a good level of QM, or, on the contrary,
organisations that have only just started their QM. To
control for this possible bias, we asked non-responders in
one multiple-choice question how they would describe the
current level of their QM.This study aims to attribute to better understanding of
the comprehensive elements needed for good diabetes
quality management in DCGs and DOCs.
Additional file
Additional file 1: Search strategy QM questionnaires.
Abbreviations
T2DM: Patient with type 2 diabetes mellitus; DCGs: Diabetes care groups;
DOCs: Diabetes outpatient clinics; ACO: Accountable Care Organization;
QM: Quality management; QI: Quality improvement; GP: General Practitioner.
Competing interests
All authors declare no competing interests.
Authors’ contributions
GR, CB and JG were responsible for identifying the research question, the
design of the study, the acquisition of funding. MC coordinated the study.
GR, LL, JG, KV, KG and MC developed the questionnaires. KV designed the
website. JG and KV supported the intervention. MC researched the data,
conducted the analysis and wrote the manuscript. GR, CB and LL helped to
draft the manuscript. All authors read and approved the final manuscript.
Acknowledgements
The study is part of the National Action Program Diabetes. Research grant
from the Dutch Diabetes Federation (grant no NAD 3.05).
Author details
1Julius Center for Health Sciences and Primary Care, University Medical
Centre Utrecht, Heidelberglaan 100, 3508, GA Utrecht, The Netherlands.
2Centre for Nutrition, Prevention and Health Services, National Institute of
Public Health and the Environment, A. van Leeuwenhoeklaan 9, 3721, MA
Bilthoven, The Netherlands. 3Knowledge Centre for Shared Care, Dr
Spanjaardsweg 11, 8000, GK Zwolle, The Netherlands.
Received: 1 March 2013 Accepted: 27 March 2013
Published: 5 April 2013
References
1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK,
Farzadfar F, Khang YH, Stevens GA, et al: National, regional, and global
trends in fasting plasma glucose and diabetes prevalence since 1980:
systematic analysis of health examination surveys and epidemiological
studies with 370 country-years and 2.7 million participants. Lancet 2011,
378:31–40.
2. Plochg T, Klazinga NS: Community-based integrated care: myth or must?
Int J Qual Health Care 2002, 14:91–101.
3. Bodenheimer T: Coordinating care–a perilous journey through the health
care system. N Engl J Med 2008, 358:1064–1071.
4. Sluijs EM, Wagner C: Progress in the implementation of Quality
Management in Dutch health care: 1995–2000. Int J Qual Health Care
2003, 15:223–234.
5. Bohmer RM, Lee TH: The shifting mission of health care delivery
organizations. N Engl J Med 2009, 361:551–553.
6. Sluiter AC, Van Wijland JJ, Arntzenius AB, Bots AFE, Dijkhorst-Oei LT, Van
der Does FEE, Palmen JVH, Potter van Loon BJ, Schaper NC, Van Balen
JAM: Landelijke Transmurale Afspraak Diabetes mellitus type 2
[Dutch transmural agreement on Diabetes mellitus type 2]. Huisarts
Wet 2012, 55:1–12.
7. Struijs JN, Mohnen SM, Molema CCM, de Jong-van Til JT, Baan CA: Effect
van Integrale Bekostiging op Curatieve Zorgkosten. Een analyse voor
diabeteszorg en vasculair risicomangement op basis van registratiebestanden
Vektis, 2007–2010 [Effect of bundled payment on curative cost of care. An
analysis on diabetes care and cardiovascular risk management based on the
Vektis database, 2007–2010]. Bilthoven: RIVM; 2012.
8. Struijs JN, Baan CA: Integrating care through bundled payments–lessons
from The Netherlands. N Engl J Med 2011, 364:990–991.
Campmans-Kuijpers et al. BMC Health Services Research 2013, 13:129 Page 10 of 10
http://www.biomedcentral.com/1472-6963/13/1299. Luft HS: Becoming accountable-opportunities and obstacles for ACOs. N
Engl J Med 2010, 363:1389–1391.
10. Rosenthal MB, Cutler DM, Feder J: The ACO rules–striking the balance
between participation and transformative potential. N Engl J Med
2011, 365:e6.
11. DiabeteszorgBeter (Better Diabetes Care). http://www.giantt.nl/
DiabeteszorgBeter.pdf.
12. de Jong-van Til JT, Lemmens LC, Baan CA, Struijs JN: De organisatie van
zorggroepen anno 2011. Huidige stand van zaken en de ontwikkelingen in de
afgelopen jaren [The organisation of care groups in 2011. Current state and
recent developments]. Bilthoven: RIVM; 2012.
13. De Grauw WJC: NDF Care Standard. Transparency and quality of diabetes
care for people with type 2 diabetes. Amersfoort: Nederlandse Diabetes
Federatie; 2007.
14. NIV guidelines (guidelines for Dutch endocrinologists). http://www.
internisten.nl/gzi2.
15. van Til JT, de Wildt JE, Struijs JN: De organisatie van zorggroepen anno 2010;
Huidige stand van zaken en de ontwikkelingen in de afgelopen jaren [The
organisation of care groups in 2010. Current state and recent developments].
Bilthoven: RIVM; 2010.
16. Duckers M, Makai P, Vos L, Groenewegen P, Wagner C: Longitudinal
analysis on the development of hospital quality management systems in
the Netherlands. Int J Qual Health Care 2009, 21:330–340.
17. Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, Halperin I,
Vachon B, Ramsay T, Manns B, et al: Effectiveness of quality improvement
strategies on the management of diabetes: a systematic review and
meta-analysis. Lancet 2012, 379:2252–2261.
18. van Thiel G, Oosterwegel M, Vermaas A: Good scientists make good science.
Utrecht: UMC Utrecht; 2011.
19. Care Institutions Quality Act. http://wetten.overheid.nl/BWBR0018906.
20. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A:
Improving chronic illness care: translating evidence into action. Health
Aff (Millwood) 2001, 20:64–78.
21. Onderbouwing HKZ-model versie 2008 [Basis of HKZ model, version 2008].
http://www.hkz.nl/images/stories/publicaties/def%20HKZ%20Onderbouwing%
20HKZ%20model.pdf.
22. Hertz HS, Reimann CW, Bostwick MC: The Malcolm Baldrige National
Quality Award concept: could it help stimulate or accelerate health care
quality improvement? Qual Manag Health Care 1994, 2:63–72.
23. EFQM. http://www.efqm.org.
24. INK-management model. http://www.ink.nl/nl/p4bd80e5bc3a81/ink-
filosofie.html.
25. Nabitz U, Klazinga N, Walburg J: The EFQM excellence model: European
and Dutch experiences with the EFQM approach in health care.
European Foundation for Quality Management. Int J Qual Health Care
2000, 12:191–201.
26. Wagner C, De Bakker DH, Groenewegen PP: A measuring instrument for
evaluation of quality systems. Int J Qual Health Care 1999, 11:119–130.
27. Standard ENQual hospital pilot questionnaire English 27 12 07.
http://www.docstoc.com/docs/112961266/Standard-ENQual-hospital-
pilot-questionnaire-English-27-12-07.
28. Minkman M, Ahaus K, Fabbricotti I, Nabitz U, Huijsman R: A quality
management model for integrated care: results of a Delphi and Concept
Mapping study. Int J Qual Health Care 2009, 21:66–75.
29. Streiner DL, Norman GR: Health Measurement Scales. A practical guide to
their development and use. Oxford: University Press; 2008.
30. Savage J: Ethnography and health care. BMJ 2000, 321:1400–1402.
doi:10.1186/1472-6963-13-129
Cite this article as: Campmans-Kuijpers et al.: Defining and improving
quality management in Dutch diabetes care groups and outpatient
clinics: design of the study. BMC Health Services Research 2013 13:129.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
